Ron Kurtz, M.D.

Ron Kurtz, M.D.

Chief Executive Officer, President and DirectoratRxSight· In proxies 2022–2025

Pay in FY2025-33% from the year before · RxSight stock -69.7% the same year

Ron Kurtz, M.D. was paid $4.7M in FY2025 (Dec), down 33%. RxSight stock fell 69.7% that year.

Pay$100 in the stock at the end of FY21 → $93
Pay is from the Summary Compensation Table of each RxSight proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. RxSightPublic company · 4 yr
    • Chief Executive Officer, President and Director2022 – Present · 4 yrStock in role -53%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?